drug shortages

R&D

pharmaphorum podcast Episode 223, Shawn Hodges, Revelation Pharma

On US drug shortages and compounding pharmacies, with Shawn ...

Shawn Hodges, CEO of Revelation Pharma, discusses the true state of drug shortages in the US at the moment and the role of compounding pharmacies.

News

Compounders cast adrift after semaglutide shortage ends

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.

Market Access

Navigating new risks: How China’s Anti-Espionage Law could i...

The pharmaceutical industry is facing another challenge as China seems to strengthen its Anti-Espionage Law, which introduces uncertainties that could disrupt the global supply of essential

Patients

Managing the UK's ADHD medication supply crisis with accessi...

Recent statistics from the NHS have highlighted an increase in prescribed medicine for attention deficit hyperactivity disorder (ADHD) over the past year,

News